Full length articleDevelopment of an innervated tissue-engineered skin with human sensory neurons and Schwann cells differentiated from iPS cells
Graphical abstract
Introduction
Although the primary purpose of cutaneous sensory innervation is the perception of sense of touch, pain and temperature, it also plays a major role in skin physiology and pathology. Indeed, sensory neurons are able to trigger a neurogenic inflammation upon stimulation through the release of neuropeptides. This process induces microvascular vasodilation and an increase in vascular permeability, along with immune cells chemotaxis and activation [1]. Consequently, neuronal triggering is intimately combined with the local innate immune response early after an injury to promote tissue inflammation. Moreover, it has more recently been shown that sensory neurons are also involved in the direct recognition of pathogens through the same molecular pathways as immune cells, such as Toll Like Receptors (TLRs) [2]. The density of cutaneous innervation as well as the high speed of neural action potentials constitute major advantages for the detection of danger signals. Thus, the in vitro development of a human skin integrating a nerve network represents an essential first step towards detailed studies on the interaction of nociceptor neurons with endothelial and immune cells and the regulation of neurogenic inflammation. We previously created an innervated TES including sensory neurons obtained from mouse embryos. These neurons were cultured underneath the tissue and were shown to build a dense nerve network that reached the epidermis through the whole thickness of the dermal compartment [3], [4]. Neurons released neuropeptides such as SP that was shown to enhance reepithelialization in an in vitro model of wound healing [5]. Whereas murine neuropeptides successfully activated human cells, their animal origin in a human tissue-engineered skin model could be a limitation for further studies, all the more that dorsal root ganglion neurons are extracted at an early embryonic developmental stage (E12 to E14). To develop a more reliable innervated skin model, the use of human sensory neurons is highly desirable, especially for cosmetic research and development in Europe where the use of animal cells is banned.
Fortunately, the technology allowing the differentiation of neuronal cells from human skin fibroblasts induced to become pluripotent stem cells (iPSC) is now widely available [6].
Some research groups succeeded in differentiating iPSC into sensory neurons, albeit with low degrees of purity and cell yields, and these studies did not attempt to create tridimensional networks [7], [8], [9], [10], [11], [12], [13], [14]. To study neurogenic inflammation, it is crucial that the sensory neurons differentiated from human iPS cells express the transient receptor potential cation channel subfamily (TRPV1, TRPV2, TRPV3, TRPA1) that regulate neuropeptides release [15]. Indeed, a challenge with hot temperature or irritant compounds like capsaicin or eugenol should drive activation of TRPVs and subsequent release of neuropeptides, mainly Substance P (SP) and Calcitonin gene-related peptide (CGRP), from peptidergic sensory neurons. Moreover, sensory neurons should express the tropomyosin receptor kinase A (TRKA) responsible for the binding to nerve growth factor (NGF), necessary for their survival [12].
Here, we propose a complete method to differentiate pure, functional sensory neurons and Schwann cells from human iPSCs and their combination in a 3D culture system to generate a fully human tissue-engineered skin model. It will be a highly valuable tool to study in vitro the relationship between human sensory nerves and skin physiopathology.
Section snippets
Cell culture
All human cells used in this work were obtained with informed consent from the donors; The study was approved by the CHU de Quebec-Université Laval research ethics review board.
Fibroblasts and keratinocytes were isolated from human skin biopsies after breast reductive surgeries as previously described [16].
Human keratinocytes were cultured in flasks on a feeder layer of irradiated 3T3 mouse fibroblasts in DHc medium consisting of a 3:1 ratio of DMEM/Ham's F12 (Gibco, Gaithersburg, MD) with
Sensory neurons were differentiated from human iPS cells with high purity, high yield and expressed specific markers
Human fibroblasts-derived iPSCs cultured on Geltrex-coated 6-well plates (2D culture) were allowed to differentiate for 22 days and were stained with specific markers for sensory neurons to confirm their identity. Based on the expression of BRN3A (a transcription factor expressed in the developing sensory neurons [21], [22], neurofilament M (NFM, 150 kDa [23]) and TRPV1, the optimal maturation time was observed at day 19, and was followed by a decrease in the number of cells at day 22 (
Discussion
The aim of this work was to generate human iPSC-derived sensory neurons to be used in place of rodent neurons to prepare innervated tissue-engineered skin models. The animal origin of neurons in these models does not seem to critically compromise their ability to interact with most human skin cells, notably because neuropeptides are highly conserved among species. However, interspecies differences cannot be ruled out. Finally, the use of animal cells has been banned in the European Union for
Declaration of interest
None.
Author contribution
QM and M-JB contributed to the conception, design and achievement of experiments.
TDSB and SB participated to the acquisition of data.
VF participated in interpretation of data and critically revised the article.
FB contributed to the study conception and design, analysis of data, drafting of the article and gave final approval of the submitted version.
Acknowledgments
The authors acknowledge Dr. Jack Puymirat and the iPS-Quebec platform of the CHU de Québec-Université Laval research center for the production of the human iPS cell lines used in this work.
Funding: This work was supported by the CQDM (Centre Québécois pour la Découverte du Médicament), Pierre Fabre Dermocosmétique (Toulouse, France) and the Quebec Network for Cell and Tissue Therapies – ThéCell (a thematic network supported by the Fonds de recherche du Québec–Santé). QM and VF were supported by
References (28)
- et al.
Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance
J. Invest. Dermatol.
(2006) - et al.
Hair follicles guide nerve migration in vitro and in vivo in tissue-engineered skin
J. Invest. Dermatol.
(2011) - et al.
Improvement of human keratinocyte isolation and culture using thermolysin
Burns
(1993) - et al.
Improvement of nerve regeneration in tissue-engineered skin enriched with Schwann cells
J. Invest. Dermatol.
(2009) - et al.
Brn3a/Pou4f1 regulates dorsal root ganglion sensory neuron specification and axonal projection into the spinal cord
Dev. Biol.
(2012) - et al.
Cutaneous denervation of psoriasiform mouse skin improves acanthosis and inflammation in a sensory neuropeptide-dependent manner
J. Invest. Dermatol.
(2011) - et al.
Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology
Nat. Neurosci.
(2012) - et al.
In vitro development of a tissue-engineered model of peripheral nerve regeneration to study neurite growth
FASEB J.
(2003) - et al.
Sensory neurons accelerate skin reepithelialization via substance P in an innervated tissue-engineered wound healing model
Tissue Eng. Part A
(2014) - et al.
Induced pluripotent stem cell technology: a decade of progress
Nat. Rev. Drug Discov.
(2017)
PIEZO2 is required for mechanotransduction in human stem cell-derived touch receptors
Nat. Neurosci.
Induced pluripotent stem cells from friedreich ataxia patients fail to upregulate frataxin during in vitro differentiation to peripheral sensory neurons
Stem Cells Dev.
Modeling pain in vitro using nociceptor neurons reprogrammed from fibroblasts
Nat. Neurosci.
Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors
Nat. Biotechnol.
Cited by (65)
A sustainable strategy for generating highly stable human skin equivalents based on fish collagen
2024, Biomaterials AdvancesAdvanced function, design and application of skin substitutes for skin regeneration
2024, Materials Today BioCo-culture system of human skin equivalents with mouse neural spheroids
2023, Journal of Bioscience and BioengineeringProduction of innervated bronchial epithelium from a blood sample
2023, Revue des Maladies RespiratoiresAdvances in skin-on-a-chip and skin tissue engineering
2023, Principles of Human Organs-on-Chips
- 1
Both authors contributed equally to the work.